Ignite Creation Date:
2024-05-06 @ 2:58 AM
Last Modification Date:
2024-10-26 @ 11:26 AM
Study NCT ID:
NCT02179606
Status:
COMPLETED
Last Update Posted:
2014-07-08
First Post:
2014-06-30
Brief Title:
Clinical Study to Evaluate the Efficacy and Safety of Dermalax Implant Plus
Sponsor:
Across Co Ltd
Organization:
Across Co Ltd
Study Overview
Official Title:
A Multi-Center Randomized Subject and Evaluator Blind Split-Face Comparative Medical Device Clinical Study to Evaluate the Efficacy and Safety of Dermalax Implant Plus to Restylane Sub-Q for Correction of Nasolabial Folds
Status:
COMPLETED
Status Verified Date:
2014-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study is to verify that Dermalax Implant Plus is not inferior to the reference device Restylane Sub-Q in terms of efficacy and safety in the correction of nasolabial folds
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None